Open the map

ModernaMRNA

Biotech & innovation · NASDAQ · USA

$197.00
Up 0.3% todayClose

Up 566.3% this year and +192.8% since June 26, ahead of the life science sector at +10.7%. Moderna buys from 1 mapped company.

Market cap
$78.6B
This year
+566.3%
1 year
+618.7%
P/E
n/a
P/S
35.3
P/B
11.6

Price vs the life science sector

since Jun 26MRNALife science sector, equal weight
Moderna (MRNA) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. MRNA: +192.8% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+50%+100%+150%+200%Jun 26AugSepOct 8MRNA +192.8%Sector +10.7% Moderna (MRNA) vs the Life science sector indexDaily closes from Jun 26, 2026 to Oct 8, 2026, each line rebased to its own first value. MRNA: +192.8% from Jun 26, 2026 to Oct 8, 2026. Life science sector index: +10.7% from Jun 26, 2026 to Oct 8, 2026.0%+100%+200%Jun 26AugSepOct 8MRNA+192.8%Sector+10.7%

Supply chain

1 supplier
SUPPLIERS →→ CUSTOMERSThermo Fisher Scientific (TMO)TMOThermo Fisher Scien…−1.5%None mappedMRNAModerna

Suppliers 1

Open the full chain →

About Moderna

Built on mRNA, the technology behind its covid vaccine. The pipeline pushes the same platform into further vaccines and into oncology.

Theme exposure

BiotechmRNAVaccines

Products

  • mRNA vaccines
  • Oncology pipeline
  • Rare diseases

Competitors

Risks

  • Declining covid revenue
  • Pipeline still maturing

Same segment: Biotech & innovation

Innovation-driven biotech companies focused on novel treatment modalities. Segment 3 of 8 in the Medicine, pharma & life science value chain.

AmgenAMGN−1.4%Gilead SciencesGILD+0.2%Vertex PharmaceuticalsVRTX−0.5%RegeneronREGN−0.3%BiogenBIIB−1.7%Alnylam PharmaceuticalsALNY+0.1%United TherapeuticsUTHR−2.2%IncyteINCY−0.6%

Compare MRNA

Side by side with the largest companies in the same segment.

MRNA vs AMGNMRNA vs GILDMRNA vs VRTXMRNA vs REGNMRNA vs BIIBMRNA vs ALNY

See where Moderna sits in the full Medicine, pharma & life science map: every segment from upstream suppliers to end markets, with daily metrics.

Open the Life science value chain →